JP6807636B2 - Topical composition - Google Patents
Topical composition Download PDFInfo
- Publication number
- JP6807636B2 JP6807636B2 JP2015192887A JP2015192887A JP6807636B2 JP 6807636 B2 JP6807636 B2 JP 6807636B2 JP 2015192887 A JP2015192887 A JP 2015192887A JP 2015192887 A JP2015192887 A JP 2015192887A JP 6807636 B2 JP6807636 B2 JP 6807636B2
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- extract
- magnolia
- weight
- external composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 87
- 230000000699 topical effect Effects 0.000 title description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 85
- 239000000284 extract Substances 0.000 claims description 68
- 239000011668 ascorbic acid Substances 0.000 claims description 52
- 229960005070 ascorbic acid Drugs 0.000 claims description 52
- 235000010323 ascorbic acid Nutrition 0.000 claims description 50
- -1 ascorbic acid monophosphate ester Chemical class 0.000 claims description 32
- 230000002087 whitening effect Effects 0.000 claims description 28
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 3
- SWGARUWMPUMTGP-SHRWCKKSSA-N (2R)-2-[(1S)-1,2-dihydroxy-3-oxobutyl]-3,4-dihydroxy-2H-furan-5-one Chemical compound C(C)(=O)C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O SWGARUWMPUMTGP-SHRWCKKSSA-N 0.000 claims description 2
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 claims description 2
- 239000001177 diphosphate Substances 0.000 claims description 2
- 235000011180 diphosphates Nutrition 0.000 claims description 2
- 159000000003 magnesium salts Chemical class 0.000 claims description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 claims description 2
- 239000001226 triphosphate Substances 0.000 claims description 2
- 235000011178 triphosphate Nutrition 0.000 claims description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 claims 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 1
- 241001125046 Sardina pilchardus Species 0.000 claims 1
- 235000019512 sardine Nutrition 0.000 claims 1
- 241000218378 Magnolia Species 0.000 description 46
- 241000196324 Embryophyta Species 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 27
- 229920002125 Sokalan® Polymers 0.000 description 25
- 238000000605 extraction Methods 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 22
- 238000009472 formulation Methods 0.000 description 21
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 18
- 235000004789 Rosa xanthina Nutrition 0.000 description 17
- 241000220222 Rosaceae Species 0.000 description 17
- 150000005846 sugar alcohols Polymers 0.000 description 17
- 238000011282 treatment Methods 0.000 description 16
- 239000007788 liquid Substances 0.000 description 15
- 239000000843 powder Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 235000019437 butane-1,3-diol Nutrition 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 244000141353 Prunus domestica Species 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 12
- 230000008099 melanin synthesis Effects 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 240000004580 Magnolia hypoleuca Species 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 238000000638 solvent extraction Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000002562 thickening agent Substances 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000218377 Magnoliaceae Species 0.000 description 6
- 208000003351 Melanosis Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 241000010428 Alpinia katsumadae Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 244000078534 Vaccinium myrtillus Species 0.000 description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 206010008570 Chloasma Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 244000019459 Cynara cardunculus Species 0.000 description 3
- 235000019106 Cynara scolymus Nutrition 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000016520 artichoke thistle Nutrition 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 2
- 241000531753 Geranium robertianum Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 241000198681 Prunus speciosa Species 0.000 description 2
- 235000003843 Prunus verecunda Nutrition 0.000 description 2
- 241001233471 Prunus verecunda Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 235000021018 plums Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- ZSJPUFLDBIJDAT-QFBIRUJASA-N (2R)-2-[(1S)-1,2-dihydroxyhexyl]-3,4-dihydroxy-2H-furan-5-one Chemical compound C(CCC)C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O ZSJPUFLDBIJDAT-QFBIRUJASA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CAKDFKUXFMLCAR-UIOGXPPZSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-methoxycarbonyl-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@]1(C)CC[C@](C[C@H]14)(C)C(=O)OC)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O CAKDFKUXFMLCAR-UIOGXPPZSA-N 0.000 description 1
- NOOLISFMXDJSKH-ZDGBYWQASA-N (2s,5r)-5-methyl-2-propan-2-ylcyclohexan-1-ol Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1O NOOLISFMXDJSKH-ZDGBYWQASA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- LMMTVYUCEFJZLC-UHFFFAOYSA-N 1,3,5-pentanetriol Chemical compound OCCC(O)CCO LMMTVYUCEFJZLC-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- LVOGXJMCDAOKSQ-UHFFFAOYSA-N 10-oxo-10-propan-2-yloxydecanoic acid Chemical compound CC(C)OC(=O)CCCCCCCCC(O)=O LVOGXJMCDAOKSQ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- IOIIFUWXIINNKX-UHFFFAOYSA-N 5-(5-chloro-2-ethoxyphenyl)-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one Chemical compound CCCc1nn(C)c2c1[nH]c(nc2=O)-c1cc(Cl)ccc1OCC IOIIFUWXIINNKX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000013298 Alpinia <beetle> Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000208947 Cynara Species 0.000 description 1
- 235000003198 Cynara Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000208150 Geraniaceae Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 241001290151 Prunus avium subsp. avium Species 0.000 description 1
- 241000392907 Prunus buergeriana Species 0.000 description 1
- 235000004411 Prunus conradinae Nutrition 0.000 description 1
- 241000814102 Prunus conradinae Species 0.000 description 1
- 235000011435 Prunus domestica Nutrition 0.000 description 1
- 235000004102 Prunus grayana Nutrition 0.000 description 1
- 240000005874 Prunus grayana Species 0.000 description 1
- 244000059026 Prunus jamasakura Species 0.000 description 1
- 235000013946 Prunus jamasakura Nutrition 0.000 description 1
- 235000015527 Prunus lannesiana Nutrition 0.000 description 1
- 235000013993 Prunus maximowiczii Nutrition 0.000 description 1
- 240000001052 Prunus maximowiczii Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000009220 Prunus speciosa Nutrition 0.000 description 1
- 235000011442 Prunus x yedoensis Nutrition 0.000 description 1
- 241000220307 Prunus yedoensis Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- JDLSRXWHEBFHNC-UHFFFAOYSA-N Ufenamate Chemical compound CCCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 JDLSRXWHEBFHNC-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- LYSPLNOMQZTGCM-IOZAQTAYSA-N [(4r,4ar,7s,7ar,12bs)-3-methyl-9-(pyridine-3-carbonyloxy)-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl] pyridine-3-carboxylate;hydrochloride Chemical compound Cl.O([C@H]1C=C[C@H]2[C@H]3CC=4C5=C(C(=CC=4)OC(=O)C=4C=NC=CC=4)O[C@@H]1[C@]52CCN3C)C(=O)C1=CC=CN=C1 LYSPLNOMQZTGCM-IOZAQTAYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940086737 allyl sucrose Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- WSWYZRBSUBMICN-UHFFFAOYSA-N azanium;2-(dimethylamino)-3-oxopent-4-ene-1-sulfonate Chemical compound [NH4+].[O-]S(=O)(=O)CC(N(C)C)C(=O)C=C WSWYZRBSUBMICN-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- WORCCYVLMMTGFR-UHFFFAOYSA-M loxoprofen sodium Chemical compound [Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 WORCCYVLMMTGFR-UHFFFAOYSA-M 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- BBEJNBLSSWFDSN-UHFFFAOYSA-N methylamino benzoate Chemical compound CNOC(=O)C1=CC=CC=C1 BBEJNBLSSWFDSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 description 1
- GLOBUAZSRIOKLN-UHFFFAOYSA-N pentane-1,4-diol Chemical compound CC(O)CCCO GLOBUAZSRIOKLN-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011970 polystyrene sulfonate Substances 0.000 description 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 229960003981 proparacaine Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 229940044609 sulfur dioxide Drugs 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- HVUCRESARJLKJG-UHFFFAOYSA-K trisodium 1-hexadecoxyhexadecane phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC HVUCRESARJLKJG-UHFFFAOYSA-K 0.000 description 1
- 229950010121 ufenamate Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、メラニンの生成を抑制し、優れた美白効果を奏する外用組成物に関する。 The present invention relates to an external composition that suppresses the production of melanin and exerts an excellent whitening effect.
皮膚のシミ、そばかす、くすみ、黒ずみ、肝斑、老人性色素斑等の色素沈着は、紫外線曝露、ホルモンの異常や物理的な刺激等が原因となってメラニンが過剰に形成され、これが皮膚内に沈着することによって生じることが分かっている。このような皮膚の色素沈着は、特に女性にとって美容上の大きな悩みとなっている。 Pigmentation of skin stains, freckles, dullness, darkening, chloasma, senile pigmented spots, etc. causes excessive formation of melanin due to exposure to ultraviolet rays, hormonal abnormalities, physical irritation, etc. It is known to be caused by deposition in. Such skin pigmentation is a major cosmetic problem, especially for women.
従来、アスコルビン酸及びその誘導体は、皮膚の色素沈着を抑制し、美白効果を奏することが知られており、美白用の外用組成物に広く使用されている。しかしながら、アスコルビン酸及びその誘導体の美白効果では、消費者ニーズを十分に満足できているとは言えないのが現状である。 Conventionally, ascorbic acid and its derivatives have been known to suppress skin pigmentation and exert a whitening effect, and are widely used in external compositions for whitening. However, the whitening effect of ascorbic acid and its derivatives cannot be said to fully satisfy consumer needs.
また、植物抽出物にも、香粧学的効果を奏するものが知られている。例えば、特許文献1において、ホオノキ抽出物には、コラゲナーゼ活性を阻害する作用があり、皮膚の老化防止に有効であることが報告されている。また、特許文献2において、プルーンの酵素分解物には、ファゴサイトーシスを抑制する作用があり、メラニン色素の体表への移動を抑制して美白効果を奏することが報告されている。しかしながら、植物抽出物単独で発揮される香粧学的効果は緩慢であり、消費者ニーズを十分に満足できないという欠点がある。 In addition, some plant extracts have a cosmetic effect. For example, in Patent Document 1, it is reported that Magnolia obovata extract has an action of inhibiting collagenase activity and is effective in preventing skin aging. Further, in Patent Document 2, it is reported that an enzymatically decomposed product of prunes has an action of suppressing phagocytosis and suppresses the movement of melanin pigment to the body surface to exert a whitening effect. However, the cosmetic effect exerted by the plant extract alone is slow, and there is a drawback that the consumer needs cannot be fully satisfied.
美白に対する消費者の要望は年々高まっており、従来の製剤技術で得られる美白効果では、消費者の要望を満足できなくなっている。そこで、今後、益々高まる消費者の要望に追従するためにも、より優れた美白効果を奏する外用組成物の開発が望まれている。 Consumers' demands for whitening are increasing year by year, and the whitening effect obtained by conventional formulation technology cannot satisfy consumers' demands. Therefore, in order to meet the ever-increasing demands of consumers in the future, it is desired to develop an external composition having a more excellent whitening effect.
本発明の目的は、メラニンの生成を効果的に抑制することにより、優れた美白効果を奏する外用組成物を提供することである。 An object of the present invention is to provide an external composition having an excellent whitening effect by effectively suppressing the production of melanin.
本発明者は、前記課題を解決すべく鋭意検討を行ったところ、アスコルビン酸及び/又はその誘導体と、モクレン科モクレン属植物の抽出物とを併用することによって、メラニンの生成抑制作用が飛躍的に高まり、格段に優れた美白効果を奏し得ることを見出した。更に、前記2つの成分と共に、バラ科サクラ属植物の抽出物を組み合わせることによって、美白効果がより一層向上することを見出した。 As a result of diligent studies to solve the above-mentioned problems, the present inventor has found that ascorbic acid and / or a derivative thereof can be used in combination with an extract of a plant belonging to the genus Magnolia of the Magnolia family to dramatically suppress the production of melanin. It was found that it can produce a remarkably excellent whitening effect. Furthermore, it has been found that the whitening effect is further improved by combining the above two components with an extract of a plant belonging to the genus Plum of the Rosaceae family.
更に、前述する成分を、水溶性増粘剤、多孔質粉体、及びトリメチルグリシンと共に製剤化することによって、優れた美白効果を奏することに加え、塗布時に、しっかりとした塗布感がありながら、べたつきが抑制され、且つさっぱりとした感触があり、塗布後には、粉っぽさが抑えられ、しかも優れた保湿感が得られることを見出した。 Furthermore, by formulating the above-mentioned components together with a water-soluble thickener, a porous powder, and trimethylglycine, an excellent whitening effect can be obtained, and at the time of application, there is a firm application feeling. It has been found that stickiness is suppressed and a refreshing feel is obtained, powderiness is suppressed after application, and an excellent moisturizing feeling can be obtained.
本発明は、これらの知見に基づいて、更に検討を重ねることにより完成したものである。即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. (A)アスコルビン酸及び/又はその誘導体、並びに(B)モクレン科モクレン属植物の抽出物を含有することを特徴とする、外用組成物。
項2. 更に、(C)バラ科サクラ属植物の抽出物を含有する、項1に記載の外用組成物。
項3. 前記(B)成分が、ホオノキの抽出物である、項1又は2に記載の外用組成物。
項4. 前記(C)成分が、プルーンの抽出物である、項1〜3のいずれかに記載の外用組成物。
項5. 前記(A)成分が、アスコルビン酸2−グルコシドである、項1〜4のいずれかに記載の外用組成物。
項6. 美白用である、項1〜5のいずれかに記載の外用組成物。
The present invention has been completed by further studies based on these findings. That is, the present invention provides the inventions of the following aspects.
Item 1. A composition for external use, which comprises (A) ascorbic acid and / or a derivative thereof, and (B) an extract of a plant belonging to the genus Magnolia of the Magnolia family.
Item 2. Item 2. The external composition according to Item 1, further comprising (C) an extract of a plant belonging to the genus Plum of the Rosaceae family.
Item 3. Item 2. The external composition according to Item 1 or 2, wherein the component (B) is an extract of Magnolia obovata.
Item 4. Item 2. The external composition according to any one of Items 1 to 3, wherein the component (C) is an extract of prunes.
Item 5. Item 2. The external composition according to any one of Items 1 to 4, wherein the component (A) is ascorbic acid 2-glucoside.
Item 6. Item 8. The external composition according to any one of Items 1 to 5, which is used for whitening.
本発明の外用組成物は、メラニンの生成抑制作用が高く、皮膚のシミ、そばかす、くすみ、黒ずみ、肝斑、老人性色素斑等の色素沈着を効果的に予防又は改善することができる。また、本発明の外用組成物の一態様では、しっかりとした塗布感がありながら、べたつきが抑制され、且つさっぱりとした感触があり、塗布後には、粉っぽさが抑えられ、しかも優れた保湿感が得られ、良好な使用感を備えることもできる。 The external composition of the present invention has a high effect of suppressing the production of melanin, and can effectively prevent or improve pigmentation such as skin spots, freckles, dullness, darkening, chloasma, and senile pigmented spots. Further, in one aspect of the external composition of the present invention, while having a firm coating feeling, stickiness is suppressed and there is a refreshing feel, and after coating, powderiness is suppressed and excellent. A moisturizing feeling can be obtained, and a good feeling of use can be provided.
本発明の外用組成物は、アスコルビン酸及び/又はその誘導体((A)成分と表記することもある)、並びにモクレン科モクレン属植物の抽出物((B)成分と表記することもある)を含有することを特徴とする。以下、本発明の外用組成物について詳述する。 The external composition of the present invention contains ascorbic acid and / or a derivative thereof (sometimes referred to as component (A)), and an extract of a plant belonging to the genus Magnolia of the Magnolia family (sometimes referred to as component (B)). It is characterized by containing. Hereinafter, the external composition of the present invention will be described in detail.
(A)アスコルビン酸及び/又はその誘導体
本発明の外用組成物は、アスコルビン酸及び/又はその誘導体を含有する。アスコルビン酸及び/又はその誘導体は、抗酸化作用があり、美白効果が知られている公知の成分である。
(A) Ascorbic acid and / or its derivative The external composition of the present invention contains ascorbic acid and / or its derivative. Ascorbic acid and / or its derivative is a known component having an antioxidant effect and a known whitening effect.
本発明で使用されるアスコルビン酸及びその誘導体については、薬学的又は香粧学的に許容されることを限度として特に制限されないが、例えば、アスコルビン酸;アスコルビン酸2−グルコシド;アスコルビン酸モノステアレート、アスコルビン酸モノパルミテート、アスコルビン酸モノオレート等のアスコルビン酸モノアルキルエステル類;アスコルビン酸モノリン酸エステル及びそのマグネシウム塩等のアスコルビン酸モノエステル類;アスコルビン酸ジステアレート、アスコルビン酸ジパルミテート、アスコルビン酸ジオレート等のアスコルビン酸ジアルキルエステル類;アスコルビン酸ジリン酸エステル及びその塩等のアスコルビン酸ジエステル類;アスコルビン酸トリステアレート、アスコルビン酸トリパルミテート、アスコルビン酸トリオレート等のトリアルキルエステル類;アスコルビン酸トリリン酸エステル等のアスコルビン酸トリエステル類;3−O−エチル,6−アセチル−アスコルビン酸、3−O−エチル,6−ブチルアスコルビン酸、3−O−エチル,6−ラウロイルアスコルビン酸、3−O−エチル,6−パルミトイルアスコルビン酸、3−O−エチル,6−オレオイルアスコルビン酸、3−O−エチル,6−ステアロイルアスコルビン酸、3−O−エチル,6−ベヘルミノイル−アスコルビン酸等が挙げられる。これらのアスコルビン酸及びその誘導体は、L体又はD体のいずれであってもよいが、好ましくはL体が挙げられる。 The ascorbic acid and its derivatives used in the present invention are not particularly limited as long as they are pharmaceutically or cosmetically acceptable, and for example, ascorbic acid; ascorbic acid 2-glucoside; ascorbic acid monostearate. , Ascorbic acid monoalkyl esters such as ascorbic acid monopalmitate and ascorbic acid monooleate; ascorbic acid monoesters such as ascorbic acid monophosphate ester and its magnesium salt; ascorbic acid distearate, ascorbic acid dipalmitate, ascorbic acid diolate and the like Acid dialkyl esters; ascorbic acid diesters such as ascorbic acid diphosphate ester and salts thereof; trialkyl esters such as ascorbic acid tristearate, ascorbic acid tripalmitate, ascorbic acid triolate; ascorbic acid triphosphates and the like Ascorbic acid triesters; 3-O-ethyl, 6-acetyl-ascorbic acid, 3-O-ethyl, 6-butylascorbic acid, 3-O-ethyl, 6-lauroyl ascorbic acid, 3-O-ethyl, 6 Examples thereof include -palmitoyl ascorbic acid, 3-O-ethyl, 6-oleyl ascorbic acid, 3-O-ethyl, 6-stearoyl ascorbic acid, 3-O-ethyl, 6-beherminoyl-ascorbic acid and the like. These ascorbic acid and its derivatives may be either L-form or D-form, but L-form is preferable.
これらのアスコルビン酸及びその誘導体は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらのアスコルビン酸及びその誘導体の中でも、安定性や美白効果等の観点から、好ましくはアスコルビン酸の誘導体、更に好ましくはアスコルビン酸2−グルコシドが挙げられる。 These ascorbic acid and its derivatives may be used alone or in combination of two or more. Among these ascorbic acid and its derivatives, a derivative of ascorbic acid is preferable, and ascorbic acid 2-glucoside is more preferable, from the viewpoint of stability and whitening effect.
本発明の外用組成物における(A)成分の含有量については、当該外用組成物の製剤形態等に応じて適宜設定すればよいが、例えば、0.1〜10重量%、好ましくは0.3〜8重量%、更に好ましくは0.5〜7重量%が挙げられる。 The content of the component (A) in the external composition of the present invention may be appropriately set according to the formulation form of the external composition, etc., and is, for example, 0.1 to 10% by weight, preferably 0.3. -8% by weight, more preferably 0.5-7% by weight.
(B)モクレン科モクレン属植物の抽出物
本発明の外用組成物は、アスコルビン酸及び/又はその誘導体と共に、モクレン科モクレン属植物の抽出物を含有する。このように、アスコルビン酸及び/又はその誘導体とモクレン科モクレン属植物の抽出物とを併用することによって、メラニンの生成抑制作用が飛躍的に高まり、格段に優れた美白効果を奏することが可能になる。
(B) Extract of Magnolia family Magnolia plant The external composition of the present invention contains an extract of Magnolia family Magnolia plant together with ascorbic acid and / or a derivative thereof. In this way, by using ascorbic acid and / or a derivative thereof in combination with an extract of a plant belonging to the genus Magnolia of the Magnolia family, the effect of suppressing the production of melanin is dramatically enhanced, and it is possible to achieve a remarkably excellent whitening effect. Become.
モクレン科モクレン属植物の抽出物は、抽出原料としてモクレン科モクレン属植物を使用して溶媒抽出処理を行うことにより得ることができる。 An extract of a Magnolia family Magnolia plant can be obtained by performing a solvent extraction treatment using a Magnolia family Magnolia plant as an extraction raw material.
抽出原料として使用されるモクレン科モクレン属植物としては、「原色世界植物大図鑑」(昭和61年4月20日初版発行、株式会社北隆館)に掲載されているもの等が挙げられ、具体的には、マグノリア・ビロバ、ボウシュンカ、ハクモクレン、コブシ(ヤマアララギ、コブシハジカミ、イモウエバナ)、モクレン(モクレンゲ、シモクレン)、カラホオ(シナホオノキ)、マグノリア・スプレンゲリ、ホオノキ(ホオガシワ、ホオガシワノキ、ウマノベロ)等が挙げられる。これらの抽出原料植物の中から、1種の植物を単独で使用してもよく、また2種以上の植物を組み合わせて使用してもよい。これらの抽出原料の中でも、より一層優れた美白効果を奏させるという観点から、好ましくはホオノキが挙げられる。 Examples of Magnolia magnolia plants used as extraction raw materials include those listed in the "Primary Color World Botanical Encyclopedia" (first edition published on April 20, 1986, Kitatakakan Co., Ltd.). Magnolia magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia, magnolia .. From these extraction raw material plants, one kind of plant may be used alone, or two or more kinds of plants may be used in combination. Among these extraction raw materials, Magnolia obovata is preferably mentioned from the viewpoint of exerting an even more excellent whitening effect.
モクレン科モクレン属植物の抽出物は、当該植物の樹皮から抽出されたものであればよいが、抽出対象となる部位は、樹皮以外に、必要に応じて、花、花穂、果皮、果実、茎、葉、枝、枝葉、幹、根茎、根、種子等が含まれてもよく、更には全木であってもよい。 The extract of the Magnolia family Magnolia genus plant may be extracted from the bark of the plant, but the site to be extracted is not only the bark but also flowers, spikes, fruit bark, fruits and stems as needed. , Leaves, branches, branches and leaves, trunks, bark, roots, seeds and the like may be included, and may be a whole tree.
また、モクレン科モクレン属植物の溶媒抽出処理に使用される抽出溶媒としては、例えば、水;メタノール、エタノール、プロパノール、イソプロピルアルコール、ブタノール、イソブタノール等の炭素数1〜5の低級アルコール;プロピレングリコール、1,3−ブチレングリコール、グリセリン等の多価アルコール;及びこれらの混合液等が挙げられる。これらの抽出溶媒の中でも、好ましくは、水、炭素数1〜5の低級アルコールと水の混合液、多価アルコールと水の混合液、更に好ましくは水、エタノールと水の混合液、1,3−ブチレングリコールと水の混合液、プロピレングリコールと水の混合液が挙げられる。 Examples of the extraction solvent used for the solvent extraction treatment of plants of the genus Mokuren of the family Mokuren include water; lower alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propanol, isopropyl alcohol, butanol, and isobutanol; and propylene glycol. Polyhydric alcohols such as 1,3-butylene glycol and glycerin; and mixtures thereof and the like can be mentioned. Among these extraction solvents, preferably water, a mixed solution of lower alcohol and water having 1 to 5 carbon atoms, a mixed solution of polyhydric alcohol and water, and more preferably water, a mixed solution of ethanol and water, 1, 3 -A mixture of butylene glycol and water, and a mixture of propylene glycol and water can be mentioned.
抽出溶媒として、炭素数1〜5の低級アルコール及び/又は多価アルコールと水の混合液を使用する場合、炭素数1〜5の低級アルコール及び/又は多価アルコールの濃度については、特に制限されないが、例えば、炭素数1〜5の低級アルコール及び/又は多価アルコールの合計で20〜90重量%、好ましくは30〜85重量%が挙げられる。 When a mixed solution of a lower alcohol having 1 to 5 carbon atoms and / or a polyhydric alcohol and water is used as the extraction solvent, the concentration of the lower alcohol and / or the polyhydric alcohol having 1 to 5 carbon atoms is not particularly limited. However, for example, the total of lower alcohols having 1 to 5 carbon atoms and / or polyhydric alcohols is 20 to 90% by weight, preferably 30 to 85% by weight.
モクレン科モクレン属植物の抽出物は、上記抽出対象植物部位をそのまま、或いは必要に応じて、乾燥、細切、破砕、圧搾、酵素処理、煮沸或いは発酵処理したものを、上記抽出溶媒により抽出することによって得られる。溶媒抽出処理としては、通常用いられている植物抽出物の抽出方法を採用することができ、具体的には、冷浸、温浸等の浸漬法;加温下で攪拌する方法;又はパーコレーション法等が挙げられる。 The extract of the Magnolia family Magnolia genus plant is obtained by extracting the plant part to be extracted as it is or, if necessary, dried, shredded, crushed, squeezed, enzyme-treated, boiled or fermented with the above-mentioned extraction solvent. Obtained by As the solvent extraction treatment, a commonly used method for extracting a plant extract can be adopted. Specifically, a dipping method such as cold immersion or warm immersion; a method of stirring under warming; or a percolation method. And so on.
前記溶媒抽出処理によって得られた抽出物は、液状の状態のままで使用してもよいが、また必要に応じて、濃縮、乾燥等の処理に供して濃縮物や乾燥物として使用してもよい。また濃縮又は乾燥後、得られた濃縮物又は乾燥物を非溶解性溶媒で洗浄して精製して用いてもよく、またこれを更に適当な溶剤に溶解若しくは懸濁して用いることもできる。 The extract obtained by the solvent extraction treatment may be used in a liquid state, or may be used as a concentrate or a dried product by subjecting it to treatments such as concentration and drying, if necessary. Good. Further, after concentration or drying, the obtained concentrate or dried product may be washed with an insoluble solvent to be purified and used, or this may be further dissolved or suspended in a suitable solvent for use.
また、モクレン科モクレン属植物の抽出物として、簡便には商業的に入手できるものを使用することもできる。例えば、ホオノキの樹皮の抽出物としては、一丸ファルコス株式会社製の「ファルコレックス ホオノキB」、「ファルコレックス ホオノキE」等が挙げられる。 In addition, as an extract of a plant belonging to the genus Magnolia of the Magnolia family, a commercially available extract can be conveniently used. For example, examples of the bark extract of Magnolia obovata include "Falcolex Magnolia B" and "Falcolex Magnolia E" manufactured by Ichimaru Falcos Co., Ltd.
本発明の外用組成物における(B)成分の含有量については、当該外用組成物の製剤形態等に応じて適宜設定すればよいが、例えば、(B)成分の乾燥重量換算で、0.00001重量%以上であり、具体的には、0.00001〜0.1重量%が挙げられる。より一層優れた美白効果を奏させるという観点から、本発明の外用組成物における(B)成分の含有量として、(B)成分の乾燥重量換算で、好ましくは0.00005〜0.05重量%、更に好ましくは0.0001〜0.01重量%が挙げられる。 The content of the component (B) in the external composition of the present invention may be appropriately set according to the formulation form of the external composition, etc., but for example, 0.00001 in terms of dry weight of the component (B). It is by weight% or more, and specific examples thereof include 0.00001 to 0.1% by weight. From the viewpoint of producing an even more excellent whitening effect, the content of the component (B) in the external composition of the present invention is preferably 0.00005 to 0.05% by weight in terms of the dry weight of the component (B). , More preferably 0.0001 to 0.01% by weight.
また、本発明の外用組成物において、(A)成分と(B)成分の比率は、前述する各含有量に応じて定まるが、より一層優れた美白効果を奏させるという観点から(A)成分100重量部当たり、(B)成分の乾燥重量換算で、0.001重量部以上、好ましくは0.001〜1重量部、より好ましくは0.005〜0.5重量部、更に好ましくは0.01〜0.1重量部が挙げられる。 Further, in the external composition of the present invention, the ratio of the component (A) to the component (B) is determined according to each of the above-mentioned contents, but the component (A) is obtained from the viewpoint of producing an even more excellent whitening effect. In terms of dry weight of the component (B) per 100 parts by weight, 0.001 parts by weight or more, preferably 0.001 to 1 part by weight, more preferably 0.005 to 0.5 parts by weight, still more preferably 0. 01 to 0.1 parts by weight can be mentioned.
(C)バラ科サクラ属植物の抽出物
本発明の外用組成物には、(A)成分及び(B)成分に加えて、バラ科サクラ属植物の抽出物((C)成分と表記することもある)が含まれていてもよい。(A)成分及び(B)成分と共に、バラ科サクラ属植物の抽出物が含まれている場合には、美白効果がより一層向上させることが可能になる。
(C) Extract of Rosaceae Plums In addition to the components (A) and (B), the external composition of the present invention shall be referred to as the extract of Rosaceae Plums ((C) component). Also) may be included. When an extract of a plant belonging to the genus Plum of the Rosaceae family is contained together with the components (A) and (B), the whitening effect can be further improved.
バラ科サクラ属植物の抽出物は、抽出原料としてバラ科サクラ属植物を使用して溶媒抽出処理を行うことにより得ることができる。 An extract of a Rosaceae Plum can be obtained by subjecting a solvent extraction treatment using a Rosaceae Plum as an extraction raw material.
抽出原料として使用されるバラ科サクラ属植物としては、「原色世界植物大図鑑」(昭和61年4月20日初版発行、株式会社北隆館)に掲載されているもの等が挙げられ、具体的には、プルーン(セイヨウスモモ)、アンズ(カラモモ)、プルヌス・コンラディナエ、カスミザクラ(ケヤマザクラ)、チョウジザクラ、イヌザクラ、ウワミズザクラ、ヤマザクラ、マメザクラ(フジザクラ)、シダレザクラ(イトザクラ)、ニワウメ(コウメ、リンショウバイ)、カンザン(セキヤマ)、オオシマザクラ、ミヤマザクラ、ウメ、ミネザクラ、ブンゴウメ、チシマザクラ、モモ、エドヒガン(ウバヒガン)、スモモ(ハタンキョウ)、オオヤマザクラ、リンボク(ヒイラギガシ)、シウリザクラ(ミヤマイヌザクラ、シオリザクラ)、ヒガンザクラ(コヒガンザクラ)、ソメイヨシノ、バクチノキ(ビラン、ビランジュ)等が挙げられる。これらの抽出原料植物の中から、1種の植物を単独で使用してもよく、また2種以上の植物を組み合わせて使用してもよい。これらの抽出原料の中でも、美白効果の向上作用をより一層高めるという観点から、好ましくはプルーンが挙げられる。 Examples of plants belonging to the genus Prunus speciosa used as raw materials for extraction include those listed in the "Primary Color World Plant Encyclopedia" (first edition published on April 20, 1986, Kitatakakan Co., Ltd.). Prunus (Yoshino cherry), Anzu (Rosaceae), Prunus conradinae, Prunus verecunda (Keyama cherry), Prunus verecunda, Inuzakura, Uwamizuzakura, Yamazakura, Mamezakura (Fujizakura), Shidarezakura (Itozakura), Niwaume (Koume) , Kanzan (Sekiyama), Oshimazakura, Miyamazakura, Ume, Minezakura, Bungoume, Chishimazakura, Momo, Edohigan (Ubahigan), Sumomo (Hatankyo), Oyamazakura, Rinboku (Hiragigashi), Shiurizakura (Miyamaizakura) Higanzakura), Somei Yoshino, Bakuchinoki (Vilan, Vilange) and the like. From these extraction raw material plants, one kind of plant may be used alone, or two or more kinds of plants may be used in combination. Among these extraction raw materials, prunes are preferably mentioned from the viewpoint of further enhancing the whitening effect improving effect.
バラ科サクラ属植物の抽出物は、当該植物の果肉から抽出されたものであればよいが、抽出対象となる植物部位は、果肉以外に、必要に応じて、果皮、種子等が含まれてもよい。 The extract of a plant belonging to the genus Plum of the Rosaceae family may be extracted from the flesh of the plant, but the plant part to be extracted includes not only the flesh but also the peel, seeds and the like, if necessary. May be good.
また、バラ科サクラ属植物の溶媒抽出処理に使用される抽出溶媒としては、例えば、水;メタノール、エタノール、プロパノール、イソプロピルアルコール、ブタノール、イソブタノール等の炭素数1〜5の低級アルコール;プロピレングリコール、1,3−ブチレングリコール、1,2−ブチレングリコール、1,4−ブチレングリコール、1,5−ペンタンジオール、1,2−ペンタンジオール、1,3−ペンタンジオール、1,4−ペンタンジオール、1,3,5−ペンタントリオール等の多価アルコール;フェノキシエタノール、パラベン、エチルパラベン、メチルパラベン、プロピルパラベン;及びこれらの混合液等が挙げられる。これらの抽出溶媒の中でも、好ましくは、水、多価アルコールと水の混合液、炭素数1〜5の低級アルコールと水の混合液、更に好ましくは水、1,3−ブチレングリコールと水の混合液が挙げられる。 Examples of the extraction solvent used for solvent extraction treatment of plants belonging to the genus Sakura of the family Rose are water; lower alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propanol, isopropyl alcohol, butanol, and isobutanol; propylene glycol. 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, Polyhydric alcohols such as 1,3,5-pentantriol; phenoxyethanol, paraben, ethylparaben, methylparaben, propylparaben; and mixtures thereof and the like can be mentioned. Among these extraction solvents, water, a mixture of polyhydric alcohol and water, a mixture of lower alcohol having 1 to 5 carbon atoms and water, and more preferably water, a mixture of 1,3-butylene glycol and water are preferable. Liquid is mentioned.
抽出溶媒として、炭素数1〜5の低級アルコール及び/又は多価アルコールと水の混合液を使用する場合、炭素数1〜5の低級アルコール及び/又は多価アルコールの濃度については、特に制限されないが、例えば、炭素数1〜5の低級アルコール及び/又は多価アルコールの合計で20〜90重量%、好ましくは30〜85重量%が挙げられる。 When a mixed solution of a lower alcohol having 1 to 5 carbon atoms and / or a polyhydric alcohol and water is used as the extraction solvent, the concentration of the lower alcohol and / or the polyhydric alcohol having 1 to 5 carbon atoms is not particularly limited. However, for example, the total of lower alcohols having 1 to 5 carbon atoms and / or polyhydric alcohols is 20 to 90% by weight, preferably 30 to 85% by weight.
バラ科サクラ属植物の抽出物は、上記抽出対象植物部位をそのまま、或いは必要に応じて、乾燥、細切、破砕、圧搾、酵素処理、煮沸或いは発酵処理したものを、上記抽出溶媒により抽出処理することによって得られる。特に、本発明では、抽出処理に供されるバラ科サクラ属植物は、予め酵素処理に供しておくことが望ましい。酵素処理されたバラ科サクラ属植物を抽出原料として使用することにより、美白効果を向上させる作用が格段に高い抽出物を得ることが可能になる。 The extract of the Rosaceae Plum genus is obtained by extracting the plant part to be extracted as it is, or, if necessary, drying, shredding, crushing, squeezing, enzyme-treating, boiling or fermenting the plant with the above-mentioned extraction solvent. Obtained by doing. In particular, in the present invention, it is desirable that the Rosaceae Plum genus plant to be subjected to the extraction treatment is subjected to the enzyme treatment in advance. By using an enzyme-treated plant belonging to the genus Plum of the Rosaceae family as an extraction raw material, it becomes possible to obtain an extract having a significantly higher effect of improving the whitening effect.
バラ科サクラ属植物の酵素処理に使用される酵素については、果肉中の繊維素を分解できる繊維素分解酵素であればよく、具体的には、セルラーゼ、ヘミセルラーゼ、ペクチナーゼ等が挙げられる。これらの酵素は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 The enzyme used for the enzyme treatment of plants of the genus Plum of the Rosaceae family may be any fibrinolytic enzyme capable of decomposing fibrinoide in fruit flesh, and specific examples thereof include cellulase, hemicellulase, and pectinase. These enzymes may be used alone or in combination of two or more.
また、酵素処理条件については、特に制限されず、使用する酵素の作用温度及び作用pHの範囲内に設定し、所望の効果が得られるように酵素反応が進行するまで行えばよいが、例えば、20〜45℃で3〜24時間反応させる条件が挙げられる。バラ科サクラ属植物に酵素処理を行った後に、必要に応じて、加熱等により酵素を失活させて、溶媒抽出処理に供すればよい。 The enzyme treatment conditions are not particularly limited, and may be set within the range of the action temperature and the action pH of the enzyme to be used, and may be carried out until the enzyme reaction proceeds so that the desired effect can be obtained. Conditions include a condition of reacting at 20 to 45 ° C. for 3 to 24 hours. After the plant of the genus Plum of the Rosaceae is treated with the enzyme, the enzyme may be inactivated by heating or the like, if necessary, and subjected to the solvent extraction treatment.
溶媒抽出処理としては、通常用いられている植物抽出物の抽出方法を採用することができ、具体的には、冷浸、温浸等の浸漬法;加温下で攪拌する方法;又はパーコレーション法等が挙げられる。 As the solvent extraction treatment, a commonly used method for extracting a plant extract can be adopted. Specifically, a dipping method such as cold immersion or warm immersion; a method of stirring under warming; or a percolation method. And so on.
前記溶媒抽出処理によって得られた抽出物は、液状の状態のままで使用してもよいが、また必要に応じて、濃縮、乾燥等の処理に供して濃縮物や乾燥物として使用してもよい。また濃縮又は乾燥後、得られた濃縮物又は乾燥物を非溶解性溶媒で洗浄して精製して用いてもよく、またこれを更に適当な溶剤に溶解若しくは懸濁して用いることもできる。 The extract obtained by the solvent extraction treatment may be used in a liquid state, or may be used as a concentrate or a dried product by subjecting it to treatments such as concentration and drying, if necessary. Good. Further, after concentration or drying, the obtained concentrate or dried product may be washed with an insoluble solvent to be purified and used, or this may be further dissolved or suspended in a suitable solvent for use.
また、バラ科サクラ属植物の抽出物や、酵素処理されたバラ科サクラ属植物の抽出物として、簡便には商業的に入手できるものを使用することもできる。例えば、酵素分解したプルーンの抽出物としては、一丸ファルコス株式会社製の「クレアージュ」等が挙げられる。 In addition, as an extract of a plant belonging to the genus Plum of the Rosaceae family or an extract of a plant of the genus Plumaceae of the Rosaceae that has been treated with an enzyme, a commercially available extract can be conveniently used. For example, examples of the enzyme-decomposed prunes extract include "Creage" manufactured by Ichimaru Falcos Co., Ltd.
本発明の外用組成物における(C)成分の含有量については、当該外用組成物の製剤形態等に応じて適宜設定すればよいが、例えば、(C)成分の乾燥重量換算で、0.00001重量%以上、具体低には、0.00001〜0.1重量%が挙げられる。美白効果を向上させる作用をより一層高めるという観点から、本発明の外用組成物における(C)成分の含有量として、(C)成分の乾燥重量換算で、好ましくは0.00005〜0.01重量%、更に好ましくは0.0001〜0.001重量%が挙げられる。 The content of the component (C) in the external composition of the present invention may be appropriately set according to the formulation form of the external composition, etc., but for example, 0.00001 in terms of dry weight of the component (C). Specific lows of% by weight or more include 0.00001 to 0.1% by weight. From the viewpoint of further enhancing the action of improving the whitening effect, the content of the component (C) in the external composition of the present invention is preferably 0.00005 to 0.01 weight in terms of the dry weight of the component (C). %, More preferably 0.0001 to 0.001% by weight.
また、本発明の外用組成物において、(B)成分と(C)成分の比率は、前述する各含有量に応じて定まるが、より一層優れた美白効果を奏させるという観点から、(B)成分100重量部(乾燥重量換算)当たり、(C)成分の乾燥重量換算で、1重量部以上であり、好ましくは1〜5000重量部、より好ましくは5〜500重量部、更に好ましくは5〜100重量部、特に好ましくは10〜100重量部が挙げられる。 Further, in the external composition of the present invention, the ratio of the component (B) to the component (C) is determined according to each of the above-mentioned contents, but from the viewpoint of producing an even more excellent whitening effect, (B) In terms of dry weight of component (C), it is 1 part by weight or more, preferably 1 to 5000 parts by weight, more preferably 5 to 500 parts by weight, and further preferably 5 to 5 parts by weight per 100 parts by weight of the component (converted to dry weight). 100 parts by weight, particularly preferably 10 to 100 parts by weight.
(D)水溶性増粘剤、(E)多孔質粉体、及び(F)トリメチルグリシン
本発明の外用組成物は、前述する成分に加えて、水溶性増粘剤((D)成分と表記することもある)、多孔質粉体((E)成分と表記することもある)、及びトリメチルグリシン((F)成分と表記することもある)を含んでいてもよい。前述する成分と共に、これらの(D)〜(F)成分を一体として含む場合には、優れた美白効果に加え、塗布時に、しっかりとした塗布感がありながら、べたつきが抑制され、且つさっぱりとした感触があり、塗布後には、粉っぽさが抑えられ、しかも優れた保湿感を付与することが可能になる。
(D) Water-soluble thickener, (E) Porous powder, and (F) Trimethylglycine The external composition of the present invention is referred to as a water-soluble thickener ((D) component) in addition to the above-mentioned components. It may also contain porous powder (sometimes referred to as component (E)), and trimethylglycine (sometimes referred to as component (F)). When these (D) to (F) components are contained together with the above-mentioned components, in addition to an excellent whitening effect, stickiness is suppressed and refreshing while having a firm application feeling at the time of application. It has a smooth feel, and after application, it is possible to suppress powderiness and impart an excellent moisturizing feeling.
水溶性増粘剤としては、薬学的又は香粧学的に許容されることを限度として特に制限されないが、例えば、カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー、セルロースガム、キサンタンガム、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、ポリアクリル酸ナトリウム、カラギーナン、キサンタンガム、スクレロチウムガム、ポリスチレンスルホネート、カラヤガム、ペクチン等が挙げられる。これらの中でも、しっかりとした塗布感や保湿感をより効果的に向上させるという観点から、好ましくはカルボキシビニルポリマー、アルキル変性カルボキシビニルポリマーが挙げられる。 The water-soluble thickener is not particularly limited as long as it is pharmaceutically or cosmetically acceptable, and for example, carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, cellulose gum, xanthan gum, hydroxypropylmethyl cellulose, hydroxy. Examples thereof include ethyl cellulose, carboxymethyl cellulose, (acryloyldimethyltaurine ammonium / VP) polymer, sodium polyacrylate, carrageenan, xanthan gum, sclerothium gum, polystyrene sulfonate, karaya gum, pectin and the like. Among these, carboxyvinyl polymers and alkyl-modified carboxyvinyl polymers are preferable from the viewpoint of more effectively improving the firm coating feeling and moisturizing feeling.
力ルボキシビニルポリマーは、カルボキシル基を有する水溶性のビニルポリマーであり、具体的には、アクリル酸及び/又はメタグリル酸を主鎖として、アリルショ糖やペンタエリスリトールのアリルエーテル等による架橋構造を有するポリマーである。 The force-ruboxyvinyl polymer is a water-soluble vinyl polymer having a carboxyl group, and specifically, it has a crosslinked structure with acrylic acid and / or metaglylic acid as a main chain and allyl sucrose, pentaerythritol, or the like. It is a polymer.
また、アルキル変性カルボキシビニルポリマーは、前記カルボキシビニルポリマーのカルボキシル基の少なくとも一部がアルキル基によりエステル化されたポリマーである。アルキル変性カルボキシビニルポリマーにおいて、エステル結合によって結合しているアルキル基は、直鑽状又は分岐状のいずれであってもよい。また、当該アルキル基の炭素数については、特に制限されないが、例えば8〜35、好ましくは8〜30が挙げられる。 Further, the alkyl-modified carboxyvinyl polymer is a polymer in which at least a part of the carboxyl groups of the carboxyvinyl polymer is esterified with an alkyl group. In the alkyl-modified carboxyvinyl polymer, the alkyl group bonded by the ester bond may be in the form of a straight or branched form. The number of carbon atoms of the alkyl group is not particularly limited, and examples thereof include 8 to 35, preferably 8 to 30.
カルボキシビニルポリマー及びアルキル変性カルボキシビニルポリマーの分子量については、特に制限されないが、例えば、5重量%となるように溶解させた水溶液(pH6.5)の20℃での粘度が500mPa・s以上、好ましくは500〜100000mPa・sとなるものが挙げられる。ここで、当該粘度は、B型粘度計「TOKI SANGYO VISCOMETER TVB−10」(東機産業株式会社製)において、ローター:M3(回転速度:20rpm、時間:1分、単位:mPa・s)を使用して測定される値である。 The molecular weight of the carboxyvinyl polymer and the alkyl-modified carboxyvinyl polymer is not particularly limited, but for example, the viscosity of an aqueous solution (pH 6.5) dissolved so as to be 5% by weight at 20 ° C. is preferably 500 mPa · s or more. Is 500 to 100,000 mPa · s. Here, the viscosity is determined by using a B-type viscometer "TOKI SANGYO VISCOMETER TVB-10" (manufactured by Toki Sangyo Co., Ltd.) with a rotor: M3 (rotation speed: 20 rpm, time: 1 minute, unit: mPa · s). The value measured using.
これらの水溶性増粘剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。前述する使用感をより一層良好にするという観点から、水溶性増粘剤として、カルボキシビニルポリマーとアルキル変性カルボキシビニルポリマーを組み合わせて使用することが好ましい。カルボキシビニルポリマーとアルキル変性カルボキシビニルポリマーを組み合わせて使用する場合、これらの比率については、特に制限されないが、例えば、カルボキシビニルポリマー100重量部当たり、アルキル変性カルボキシビニルポリマーが1〜10000重量部、好ましくは50〜5000重量部、更に好ましくは10〜1000重量部が挙げられる。 These water-soluble thickeners may be used alone or in combination of two or more. From the viewpoint of further improving the above-mentioned usability, it is preferable to use a carboxyvinyl polymer and an alkyl-modified carboxyvinyl polymer in combination as the water-soluble thickener. When the carboxyvinyl polymer and the alkyl-modified carboxyvinyl polymer are used in combination, the ratio thereof is not particularly limited, but for example, the alkyl-modified carboxyvinyl polymer is preferably 1 to 10000 parts by weight per 100 parts by weight of the carboxyvinyl polymer. Is 50 to 5000 parts by weight, more preferably 10 to 1000 parts by weight.
水溶性増粘剤は、商業的に入手できるものを使用することもできる。例えば、カルボキシビニルポリマーの市販品としては、住友精化株式会社製の「AQPEC HV−501E」、「AQUP EC HV−505E」;Lubrizol Advanced Materials社製の「カーボポール940」、「カーボポール941」、「カーボポール980」;和光純薬工業株式会社製の「ハイビスワコ一103」、「ハイビスワコ一104」、「ハイビスワコ一105」;3Vシグマ社製の「シンタレンK」、「シンタレンL」等が挙げられる。また、アルキル変性カルボキシビニルポリマーの市販品としては、住友精化株式会社製の「AQUPEC HV−501ER」;Lubrizol Advanced Materials社製の「カーポポールultrez20」、「カーボポールultrez21」、「カーボポール1342」、「カーボポールETD2020」、「ペムレンTR−1」、「ペムレンTR−2」等が挙げられる。 Commercially available water-soluble thickeners can also be used. For example, as commercially available products of carboxyvinyl polymer, "AQPEC HV-501E" and "AQUP EC HV-505E" manufactured by Sumitomo Seika Chemical Industries, Ltd .; "Carbopol 940" and "Carbopole 941" manufactured by Lubrizol Advanced Materials. , "Carbopole 980"; "Hybrid Wako I 103", "Hybis Wako I 104", "Hybis Wako I 105" manufactured by Wako Pure Chemical Industries, Ltd .; "Syntaren K", "Syntaren L" manufactured by 3V Sigma, etc. Be done. As commercial products of alkyl-modified carboxyvinyl polymer, "AQUAPEC HV-501ER" manufactured by Sumitomo Seika Chemical Co., Ltd .; "Carpopole ultraz20", "Carbopole ultraz21", "Carbopole 1342" manufactured by Lubrizol Advanced Materials. , "Carbopole ETD2020", "Pemren TR-1", "Pemren TR-2" and the like.
本発明の外用組成物における(D)成分の含有量については、当該外用組成物の製剤形態等に応じて適宜設定すればよいが、例えば、0.1〜3重量%、好ましくは0.3〜2重量%、更に好ましくは0.3〜1.5重量%が挙げられる。このような含有量を満たすことにより、後述する(E)及び(F)成分との相互作用により、しっかりとした塗布感と塗布後の保湿感をより効果的に高めることが可能になる。 The content of the component (D) in the external composition of the present invention may be appropriately set according to the formulation form of the external composition, etc., and is, for example, 0.1 to 3% by weight, preferably 0.3. It is about 2% by weight, more preferably 0.3 to 1.5% by weight. By satisfying such a content, it becomes possible to more effectively enhance a firm coating feeling and a moisturizing feeling after coating by the interaction with the components (E) and (F) described later.
多孔質粉体としては、薬学的又は香粧学的に許容されることを限度として特に制限されないが、例えば、シリカ、タルク、酸化チタン、マイ力、酸化亜鉛、カオリン、硫酸バリウム、オキシ塩化ビスマス、水酸化アルミニウム、ケイ酸アルミニウム、無水ケイ酸、含水ケイ酸、モンモリロナイト等の無機粉体;ポリエステル、ポリエチレン、ポリスチレン、メタクリル酸メチル樹脂、セルロース、ナイロン、スチレンとアクリル酸の共重合体、ポリプロピレン、塩化ビニル等の高分子粉体等が挙げられる。これらの多孔質粉休は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 The porous powder is not particularly limited as long as it is pharmaceutically or cosmetically acceptable, and for example, silica, talc, titanium oxide, myrity, zinc oxide, kaolin, barium sulfate, bismuth oxychloride. , Aluminum hydroxide, aluminum silicate, silicic anhydride, hydrous silicic acid, inorganic powders such as montmorillonite; polyester, polyethylene, polystyrene, methyl methacrylate resin, cellulose, nylon, styrene and acrylic acid copolymer, polypropylene, Examples thereof include polymer powders such as vinyl chloride. These porous powder rests may be used alone or in combination of two or more.
これらの多孔質粉体の中でも、塗布中のべたつき感のなさと、さっぱり感をより一層効果的に向上させるという観点から、好ましくは、シリカ、マイカ、タルク、ナイロン、更に好ましくはシリカが挙げられる。 Among these porous powders, silica, mica, talc, nylon, and more preferably silica are preferable from the viewpoint of not sticky feeling during coating and more effectively improving the refreshing feeling. ..
多孔質粉体の平均粒径については、特に制限されないが、例えば1〜25μm、好ましくは3〜20μm、更に好ましくは3〜15μmが挙げられる。また、多孔質粉体の吸油量については、特に制限されないが、例えば50〜500ml/100g、好ましくは50〜300ml/100g、更に好ましくは50〜200ml/100gが挙げられる。また、多孔質粉体の比表面積については、特に制限されないが、例えば30〜1000m2/g、好ましくは100〜950m2/g、更に好ましくは200〜800m2/g、より好ましくは200〜600m2/gが挙げられる。ここで、多孔質粉体の平均粒径とは、JIS Z 8901:2006「試験用粉体及び試験用粒子」で定義されている「粒子の直径の算術平均値」である。また、多孔質粉体の吸油量は、JIS K5101−13−1に準拠して測定される値である。また、多孔質粉体の比表面積は、JIS K6430付属書Eに準拠して測定されるBET比表面積である。 The average particle size of the porous powder is not particularly limited, and examples thereof include 1 to 25 μm, preferably 3 to 20 μm, and more preferably 3 to 15 μm. The amount of oil absorbed by the porous powder is not particularly limited, and examples thereof include 50 to 500 ml / 100 g, preferably 50 to 300 ml / 100 g, and more preferably 50 to 200 ml / 100 g. The specific surface area of the porous powder is not particularly limited, but is, for example, 30 to 1000 m 2 / g, preferably 100 to 950 m 2 / g, more preferably 200 to 800 m 2 / g, and more preferably 200 to 600 m. 2 / g can be mentioned. Here, the average particle size of the porous powder is the “arithmetic mean value of the particle diameter” defined in JIS Z 8901: 2006 “Test powder and test particles”. The oil absorption of the porous powder is a value measured in accordance with JIS K5101-13-1. The specific surface area of the porous powder is the BET specific surface area measured in accordance with JIS K6430 Annex E.
本発明の外用組成物における(E)成分の含有量については、当該外用組成物の製剤形態等に応じて適宜設定すればよいが、例えば、0.05〜5重量%、好ましくは0.5〜3重量%、更に好ましくは1〜3重量%が挙げられる。 The content of the component (E) in the external composition of the present invention may be appropriately set according to the formulation form of the external composition, etc., and is, for example, 0.05 to 5% by weight, preferably 0.5. ~ 3% by weight, more preferably 1 to 3% by weight.
トリメチルグリシンは、アカザ科の植物や、海草、魚類、甲殻類等に存在しており、アミノ酸系保湿剤として汎用されている成分である。 Trimethylglycine is present in plants of the family Chenopodiaceae, seaweeds, fish, crustaceans, etc., and is a widely used component as an amino acid-based moisturizer.
トリメチルグリシンは、商業的に入手できるものを使用することもできる。トリメチルグリシンの市販品としては、具体的には、味の素株式会社製の「アクアデュウ AN−100」、旭化成ケミカルズ株式会社製の「アミノコート」等が挙げられる。 Commercially available trimethylglycine can also be used. Specific examples of commercially available trimethylglycine products include "Aqua Dew AN-100" manufactured by Ajinomoto Co., Inc. and "Amino Coat" manufactured by Asahi Kasei Chemicals Co., Ltd.
本発明の外用組成物において、(D)〜(F)成分を含有させる場合、(D)成分と(F)成分の比率については、(D)成分1重量部当たり、(F)成分が0.1〜6重量部であることが望ましい。このような比率を充足させることによって、前述する塗布時及び塗布後の使用感を効果的に付与することが可能になる。前述する塗布時及び塗布後の使用感をより一層効果的に付与するという観点から、(D)成分と(F)成分の比率として、(D)成分1重量部当たり、(F)成分が、好ましくは1〜4重量部、更に好ましくは1.5〜4重量部が挙げられる。 When the components (D) to (F) are contained in the external composition of the present invention, the ratio of the component (D) to the component (F) is 0 per part by weight of the component (D). .1 to 6 parts by weight is desirable. By satisfying such a ratio, it is possible to effectively impart the feeling of use during and after the above-mentioned coating. From the viewpoint of more effectively imparting the feeling of use during and after application, the ratio of component (D) to component (F) is such that component (F) per part by weight of component (D). It is preferably 1 to 4 parts by weight, more preferably 1.5 to 4 parts by weight.
本発明の外用組成物における(E)成分の含有量については、前述する(D)成分と(F)成分の比率を充足できるように適宜設定すればよいが、例えば、(D)成分の含有量が0.1〜3重量%の場合であれば、(E)成分の含有量として、0.01〜18重量%、好ましくは0.1〜12重量%、更に好ましくは0.15〜12重量%が挙げられる。 The content of the component (E) in the external composition of the present invention may be appropriately set so as to satisfy the ratio of the component (D) and the component (F) described above. For example, the content of the component (D) is contained. When the amount is 0.1 to 3% by weight, the content of the component (E) is 0.01 to 18% by weight, preferably 0.1 to 12% by weight, and more preferably 0.15 to 12%. Weight% is mentioned.
多価アルコール
本発明の外用組成物には、保湿作用の増強等を目的として、必要に応じて、多価アルコールが含まれていてもよい。
Polyhydric alcohol The external composition of the present invention may contain a polyhydric alcohol, if necessary, for the purpose of enhancing the moisturizing effect.
多価アルコールとしては、薬学的又は香粧学的に許容されることを限度として特に制限されないが、例えば、プロピレングリコール、エチレングリコール、1,3−ブチレングリコール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン等が挙げられる。これらの多価アルコールは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらの多価アルコールの中でも、好ましくは1,3−ブチレングリコール及びグリセリンが挙げられる。 The polyhydric alcohol is not particularly limited as long as it is pharmaceutically or cosmetically acceptable, and for example, propylene glycol, ethylene glycol, 1,3-butylene glycol, isoprene glycol, diethylene glycol, dipropylene glycol, etc. Glycerin and the like can be mentioned. These polyhydric alcohols may be used alone or in combination of two or more. Among these polyhydric alcohols, 1,3-butylene glycol and glycerin are preferable.
本発明の外用組成物において、多価アルコールを含有させる場合、その含有量については、使用する多価アルコールの種類、外用組成物の製剤形態等に応じて適宜設定すればよいが、例えば、0.01〜30重量%、好ましくは0.1〜20重量%、更に好ましくは1〜20重量%が挙げられる。 When the external composition of the present invention contains a polyhydric alcohol, the content thereof may be appropriately set according to the type of the polyhydric alcohol used, the formulation form of the external composition, and the like. 0.01 to 30% by weight, preferably 0.1 to 20% by weight, more preferably 1 to 20% by weight.
水
本発明の外用組成物は、所望の製剤形態にするために、必要に応じて、基剤として水を含んでいてもよい。特に、前述する(D)及び(F)成分を含有させる場合には、それらの成分を溶解させるための基剤として水を含有させることが望ましい。
Composition for external use of the water present invention, to achieve the desired formulation, if necessary, may contain water as a base. In particular, when the above-mentioned components (D) and (F) are contained, it is desirable to include water as a base for dissolving those components.
本発明の外用組成物において、水の含有量については、特に制限されないが、例えば、10〜99.5重量%、好ましくは10〜98重量%が挙げられるより具体的には、(D)及び(F)成分を含有させる場合であれば、水の含有量として、25〜95重量%、好ましくは35〜95重量%、更に好ましくは45〜95重量%が挙げられる。 In the external composition of the present invention, the content of water is not particularly limited, but more specifically, for example, 10 to 99.5% by weight, preferably 10 to 98% by weight, and more specifically (D) and When the component (F) is contained, the content of water is 25 to 95% by weight, preferably 35 to 95% by weight, and more preferably 45 to 95% by weight.
その他の成分
本発明の外用組成物は、前述する成分以外に、必要に応じて、他の薬理成分を含有していてもよい。このような薬理成分としては、例えば、抗ヒスタミン剤(ジフェンヒドラミン、ジフェンヒドラミン塩酸塩、マレイン酸クロルフェニラミン等)、局所麻酔剤(リドカイン、ジブカイン、アミノ安息香酸メチル、プロカイン、テトラカイン、ブピパカイン、メピパカイン、クロロプロカイン、プロパラカイン、メプリルカイン又はこれらの塩、オルソカイン、オキセサゼイン、オキシポリエントキシデカン、ロートエキス、ペルカミンパーゼ、テシットデシチン等)、抗炎症剤(アラントイン、グリチルリチン酸、グリチルリチン酸メチル、グリチルリチン酸ステアリル、グリチルリチン酸ジカリウム、グリチルリチン酸モノアンモニウム、グリチルレチン酸、グリチルレチン酸ピリドキシン、グリチルレチン酸ステアリル、グリチルレチン酸グリセリル、グリチルレチン酸モノグルクロニド、サリチル酸、サリチル酸メチル、サリチル酸グリコール、インドメタシン、フェルビナク、ジクロフェナクナトリウム、ロキソプロフェンナトリウム、ウフェナマート、イブプロフェンピコノール、スプロフェン、ベンダザック、スプロフェン、ブフェキサマク等)、殺菌剤(ベンザルコニウム塩化物、デカリニウム塩化物、ベンゼトニウム塩化物、セチルピリジニウム塩化物、クロルヘキシジン塩化物、グルコン酸クロルヘキシジン、イソプロピルメチルフェノール、アンモニア水、スルファジアジン、乳酸、フェノール等)、皮膚保護剤(コロジオン、ヒマシ油等)、血行促進剤(ノニル酸ワニリルアミド、ニコチン酸ベンジルエステル、カプサイシン、トウガラシエキス等)、清涼化剤(メントール、カンフル等)、ビタミン類(ビタミンA、B、D等)、ムコ多糖類(コンドロイチン硫酸ナトリウム、グルコサミン、ヒアルロン酸等)等が挙げられる。
Other Ingredients The external composition of the present invention may contain other pharmacological ingredients in addition to the above-mentioned ingredients, if necessary. Examples of such pharmacological components include antihistamines (diphenhydramine, diphenhydramine hydrochloride, chlorhexidine maleate, etc.) and local anesthetics (lydocaine, dibucaine, methyl aminobenzoate, procaine, tetracaine, bupipacaine, mepipacaine, chloroprocine). , Proparacaine, meprilkine or salts thereof, orthokine, oxesazein, oxypolyentoxydecane, funnel extract, percaminpase, tesitdecitin, etc.), anti-inflammatory agents (alantin, glycyrrhizinic acid, methyl glycyrrhizinate, stearyl glycyrrhizinate, dipotassium glycyrrhizinate, glycyrrhizinate) Monoammonium, glycyrrhetinic acid, pyridoxin glycyrrhetinate, stearyl glycyrrhetinate, glyceryl glycyrrhetinate, monoglucuronide glycyrrhetinate, salicylic acid, methyl salicylate, glycol salicylate, indomethacin, fervinac, diclofenac sodium, loxoprofen sodium, ufenamate, ibuprofenol Zack, sprofene, bufexamac, etc.), bactericides (benzalconium chloride, decalinium chloride, benzethonium chloride, cetylpyridinium chloride, chlorhexidine chloride, chlorhexidine gluconate, isopropylmethylphenol, aqueous ammonia, sulfaziazine, lactic acid, phenol Etc.), skin protectants (colodione, castor oil, etc.), blood circulation promoters (nonyl acid vanillylamide, nicotinic acid benzyl ester, capsaicin, capsicum extract, etc.), refreshing agents (menthol, camphor, etc.), vitamins (vitamin A, B, D, etc.), mucopolysaccharides (sodium chondroitin sulfate, glucosamine, hyaluronic acid, etc.) and the like.
また、本発明の外用組成物は、所望の製剤形態にするために、必要に応じて、基剤や添加剤が含まれていてもよい。このような基剤や添加剤については、薬学的に許容されることを限度として特に制限されないが、例えば、低級アルコール(エタノール、イソプロパノール等)等の水性基剤;油類(オリーブ油、サフラワー油、大豆油、つばき油、とうもろこし油、なたね油、ひまわり油、綿実油、落花生油、ラード、スクワラン、魚油等)、鉱物油(流動パラフィン、パラフィン、ゲル化炭化水素、ワセリン等)、ワックス類・ロウ類(ミツロウ、カルナウバロウ、キャンデリラロウ、セレシン、ライスワックス、マイクロクリスタリンワックス等)、エステル油(ミリスチン酸イソプロピル、アジピン酸イソプロピル、セバシン酸ジエチル、セバシン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸セチル、オレイン酸エチル、トリ2−エチルヘキサン酸グリセリル等)、脂肪酸アルキルエステル、脂肪酸(ステアリン酸、オレイン酸、パルミチン酸、ベヘン酸、リノール酸、ラノリン等)、脂肪酸エステル(パルミチン酸セチル、パルミチン酸イソプロピル、リノール酸エチル等)、中鎖脂肪酸トリグリセリド、高級アルコール(ステアリルアルコール、セタノール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、ヘキサデシルアルコール、ラノリンアルコール、コレステロール、ジヒドロコレステロール、フィトステロール、ラウリルアルコール、セトステアリルアルコール、リノレイルアルコール、オクチルドデカノール、ヘキシルデカノール、イソステアリルアルコール等)、2−エチルヘキサン酸セチル、シリコーンオイル(ジメチルポリシロキサン、環状シリコーン等)等の油性基剤;POE(10〜50モル)フィトステロールエーテル、POE(10〜50モル)ジヒドロコレステロールエーテル、POE(10〜50モル)2−オクチルドデシルエーテル、POE(10〜50モル)デシルテトラデシルエーテル、POE(10〜50モル)オレイルエーテル、POE(2〜50モル)セチルエーテル、POE(5〜50モル)ベヘニルエーテル、POE(5〜30モル)ポリオキシプロピレン(5〜30モル)2−デシルテトラデシルエーテル、POE(10〜50モル)ポリオキシプロピレン(2〜30モル)セチルエーテルなどのポリオキシエチレンアルキルエーテル、これらのリン酸・リン酸塩(POEセチルエーテルリン酸ナトリウムなど)、POE(20〜60モル)ソルビタンモノオレート、POE(10〜60モル)ソルビタンモノイソステアレート、POE(10〜80モル)グリセリルモノイソステアレート、POE(10〜30モル)グリセリルモノステアレート、POE(20〜100モル)・ポリオキシプロピレン変性シリコーン、POE・アルキル変性シリコーン、モノラウリン酸ポリエチレングリコール、モノパルミチン酸ポリエチレングリコール、モノステアリン酸ポリエチレングリコール、ジラウリン酸ポリエチレングリコール、ジパルミチン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、ジオレイン酸ポリエチレングリコール、ジリシノレイン酸ポリエチレングリコール、ポリオキシエチレン硬化ヒマシ油(5〜100)、ポリソルベート(20〜85)、グリセリン脂肪酸エステル(モノステアリン酸グリセリン等)、水素添加大豆リン脂質、水素添加ラノリンアルコール等の界面活性剤;清涼化剤(メントール、カンフル、ボルネオール、ハッカ水、ハッカ油等)、防腐剤(メチルパラベン、プロピルパラベン、安息香酸、安息香酸ナトリウム、ソルビン酸等)、着香剤(シトラール、1,8−シオネール、シトロネラール、ファルネソール等)、着色剤(タール色素(褐色201号、青色201号、黄色4号、黄色403号等)、カカオ色素、クロロフィル、酸化アルミニウム等)、pH調整剤(リン酸、塩酸、クエン酸、クエン酸ナトリウム、コハク酸、酒石酸、水酸化ナトリウム、水酸化カリウム、トリエタノールアミン、トリイソプロパノールアミン等)、湿潤剤(dl−ピロリドンカルボン酸ナトリウム液、D−ソルビトール液、マクロゴール等)、安定化剤(ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、エデト酸ナトリウム、メタリン酸ナトリウム、L−アルギニン、L−アスパラギン酸、DL−アラニン、グリシン、エリソルビン酸ナトリウム、没食子酸プロピル、亜硫酸ナトリウム、二酸化硫黄、クロロゲン酸、カテキン、ローズマリー抽出物等)、酸化防止剤、紫外線吸収剤、キレート剤、粘着剤、緩衝剤、溶解補助剤、可溶化剤、保存剤等の添加剤が挙げられる。 In addition, the external composition of the present invention may contain a base or an additive, if necessary, in order to obtain a desired formulation form. Such bases and additives are not particularly limited as long as they are pharmaceutically acceptable, but are, for example, aqueous bases such as lower alcohols (ethanol, isopropanol, etc.); oils (olive oil, saflower oil, etc.). , Soybean oil, camellia oil, corn oil, rapeseed oil, sunflower oil, cottonseed oil, peanut oil, lard, squalane, fish oil, etc.), mineral oil (liquid paraffin, paraffin, gelled hydrocarbon, vaseline, etc.), waxes and waxes. (Mitsurou, carnauba wax, candelilla wax, selecin, rice wax, microcrystalin wax, etc.), ester oil (isopropyl myristate, isopropyl adipate, diethyl sebacate, isopropyl sebacate, isopropyl palmitate, cetyl palmitate, ethyl oleate, etc.) , Tri2-ethylhexarate glyceryl, etc.), fatty acid alkyl esters, fatty acids (stearic acid, oleic acid, palmitic acid, bechenic acid, linoleic acid, lanolin, etc.), fatty acid esters (cetyl palmitate, isopropyl palmitate, ethyl linoleate, etc.) Etc.), medium chain fatty acid triglycerides, higher alcohols (stearyl alcohol, cetanol, behenyl alcohol, myristyl alcohol, oleyl alcohol, hexadecyl alcohol, lanolin alcohol, cholesterol, dihydrocholesterol, phytosterol, lauryl alcohol, cetostearyl alcohol, linoleil alcohol, octyl Oil-based bases such as dodecanol, hexyldecanol, isostearyl alcohol, etc.), cetyl 2-ethylhexanoate, silicone oil (dimethylpolysiloxane, cyclic silicone, etc.); POE (10 to 50 mol) phytosterol ether, POE (10 to 50 mol) Mol) Dihydrocholesterol ether, POE (10-50 mol) 2-octyldodecyl ether, POE (10-50 mol) decyltetradecyl ether, POE (10-50 mol) oleyl ether, POE (2-50 mol) cetyl ether , POE (5-50 mol) behenyl ether, POE (5-30 mol) polyoxypropylene (5-30 mol) 2-decyltetradecyl ether, POE (10-50 mol) polyoxypropylene (2-30 mol) Polyoxyethylene alkyl ethers such as cetyl ethers, their phosphates and phosphates (POE cetyl ether sodium phosphate, etc.), POE (20-60 mol) Solbitan monoolate, POE (10-60 mol) sorbitan monoisostearate, POE (10-80 mol) glyceryl monoisostearate, POE (10-30 mol) glyceryl monostearate, POE (20-100 mol). Polyoxypropylene-modified silicone, POE / alkyl-modified silicone, monolaurate polyethylene glycol, monopalmitate polyethylene glycol, monostearate polyethylene glycol, dilaurate polyethylene glycol, dipalmitate polyethylene glycol, distearate polyethylene glycol, dioleate polyethylene glycol, Surface activity of polyethylene glycol diricinoleate, polyoxyethylene hydrogenated castor oil (5-100), polysorbate (20-85), glycerin fatty acid ester (glycerin monostearate, etc.), hydrogenated soybean phospholipid, hydrogenated lanolin alcohol, etc. Agents: Cooling agents (mentol, camphor, borneol, peppermint water, peppermint oil, etc.), preservatives (methylparaben, propylparaben, benzoic acid, sodium benzoate, sorbic acid, etc.), flavoring agents (citral, 1,8- Cionel, citronellal, farnesol, etc.), colorants (tar pigments (brown 201, blue 201, yellow 4, yellow 403, etc.), cocoa pigments, chlorofil, aluminum oxide, etc.), pH adjusters (phosphate, hydrochloric acid, etc.) , Citric acid, sodium citrate, succinic acid, tartaric acid, sodium hydroxide, potassium hydroxide, triethanolamine, triisopropanolamine, etc.), wetting agents (dol-sodium pyrrolidone carboxylate solution, D-sorbitol solution, macrogol, etc.) ), Stabilizers (dibutylhydroxytoluene, butylhydroxyanisole, sodium edetate, sodium metaphosphate, L-arginine, L-aspartic acid, DL-alanine, glycine, sodium erythorbinate, propyl gallate, sodium sulfite, sulfur dioxide , Chlorogenic acid, catechin, rosemary extract, etc.), antioxidants, UV absorbers, chelating agents, adhesives, buffers, solubilizers, solubilizers, preservatives and other additives.
製剤形態
前記外用組成物は、経皮適用できる製剤形態である限り、その製剤形態については、特に制限されず、液状、固形状、半固形状(クリーム状、ゲル状、軟膏状、ペースト状)等のいずれであってもよい。また、本発明の外用組成物は、水性製剤、油性製剤等の非乳化製剤であってもよく、また水中油型乳化製剤、油中水型乳化製剤等の乳化製剤であってもよい。
Formulation form The external composition is not particularly limited as long as it is a formulation form that can be applied transdermally, and is liquid, solid, semi-solid (cream, gel, ointment, paste). Etc. may be used. Further, the external composition of the present invention may be a non-emulsified preparation such as an aqueous preparation or an oil-based preparation, or may be an emulsified preparation such as an oil-in-water emulsified preparation or a water-in-oil emulsified preparation.
前記外用組成物の製剤形態として、より一層効果的に美白効果を奏させるという観点から、好ましくは液状、クリーム状が挙げられる。 The formulation form of the external composition is preferably liquid or creamy from the viewpoint of exerting a whitening effect even more effectively.
また、前記外用組成物は、皮膚に適用されるものである限り、皮膚外用医薬品、化粧料、皮膚洗浄料等のいずれの製剤形態であってもよい。 In addition, the external composition may be in any form of preparation such as an external medicine for skin, a cosmetic, and a skin cleansing agent as long as it is applied to the skin.
前記外用組成物の製剤形態として、具体的には、液剤(ローション剤、スプレー剤、エアゾール剤、及び乳液剤を含む)、水溶性軟膏剤、油脂性軟膏剤、クリーム剤、フォーム剤、ジェル剤、貼付剤等の皮膚外用医薬品;軟膏、クリーム、乳液、化粧水、ローション、パック、ゲル等の化粧料;ボディーシャンプー、ヘアシャンプー、リンス等の皮膚洗浄料等が挙げられる。これらの製剤形態の中でも、好ましくは皮膚外用医薬品、更に好ましくは液剤、クリーム剤が挙げられる。これらの製剤形態への調製は、第十六改正日本薬局方 製剤総則等に記載の公知の方法に従って、製剤形態に応じた添加剤を用いて製剤化することにより行うことができる。 Specific examples of the formulation form of the external composition include liquid preparations (including lotions, sprays, aerosols, and emulsions), water-soluble ointments, oily ointments, creams, foams, and gels. , Topical skin preparations such as patches; cosmetics such as ointments, creams, milky lotions, lotions, lotions, packs and gels; skin cleaning agents such as body shampoos, hair shampoos and rinses. Among these formulation forms, a skin external preparation is preferable, and a liquid preparation and a cream preparation are more preferable. These formulations can be prepared by formulating them with additives according to the formulation according to the known method described in the 16th revised Japanese Pharmacopoeia General Regulations for Formulation.
用途
本発明の外用組成物は、メラニンの生成を抑制でき、皮膚のシミ、そばかす、くすみ、肝斑、老人性色素斑、物理的刺激による黒ずみ等の予防や改善が可能になっているので、美白用の外用組成物として好適に使用される。
Uses The external composition of the present invention can suppress the production of melanin, and can prevent or improve skin stains, freckles, dullness, chloasma, senile pigment spots, darkening due to physical irritation, etc. It is suitably used as an external composition for whitening.
以下に実施例を示して本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。 The present invention will be described in more detail with reference to Examples below, but the present invention is not limited thereto.
なお、以下の試験例及び処方例で使用した主な成分の製造元等は以下の通りである。
L−アスコルビン酸2−グルコシド:商品名「AA2G」(株式会社林原製)
ホオノキ抽出物:商品名「ファルコレックス ホオノキB」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度0.175重量%、ホオノキ(Magnolia obovata Thunberg(Magnoliaceae))の樹皮(和厚朴)を1,3−ブチレングリコール水溶液を用いて溶媒抽出処理して得られた抽出物
プルーン抽出物:商品名「クレアージュ」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度7.78重量%、プルーン(セイヨウスモモ(Prunus domestica Lindl.(Rosaceae)))の果肉を繊維素分解酵素で分解して得られるものに、水及び1,3−ブチレングリコールを加えることにより得られた抽出物
アーティチョーク葉抽出物:商品名「バイオベネフィティ」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度0.08重量%、チョウセンアザミ(Cynara scolymus L.(Compositae))の葉をエタノール溶液にて抽出して得られるエキスを濃縮、乾固して、1,3−ブチレングリコール溶液を加えることにより得られた抽出物
ヒメフウロ抽出物:商品名「プリンセスケア」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度1重量%、ヒメフウロ(Geranium robertianum L.(Geraniaceae))の全草から1,3−ブチレングリコール溶液で抽出して得られた抽出物
アルピニア・カツマダイ種子抽出物:商品名「アルピニアホワイト」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度0.2重量%、アルピニア・カツマダイ(Alpinia katsumadai Hayata(Zingiberaceae))の種子からエタノール溶液で抽出して得られるエキスを濃縮し、1,3−ブチレングリコール溶液を加えることにより得られた抽出物
チンピ抽出物:商品名「マンダリンクリア」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度3重量%、マンダリンオレンジ(Citrus reticulate Blanco(Rutaceae))の成熟した果皮を1,3−ブチレングリコール溶液にて抽出して得られた抽出物
ビルベリー葉抽出物:商品名「キュアベリー」(一丸ファルコス株式会社製)、液状、乾燥固形分濃度0.2重量%、ビルベリー(Vaccinium myrtillus L.(Ericaceae))の葉から1,3−ブチレングリコール溶液で抽出して得られた抽出物
カルボキシビニルポリマー:商品名「「カーボポール980」(Lubrizol Advanced Materials社製)
アルキル変性カルボキシビニルポリマー:商品名「カーボポールultrez20」(Lubrizol Advanced Materials社製、アルキル基の炭素数:10〜30)
シリカ:商品名「ゴッドボールD−25C」(鈴木油脂工業株式会社製)、平均粒子径7〜10μm、比表面積300〜500m2/g、吸油量70〜110ml/100g
The manufacturers of the main components used in the following test examples and prescription examples are as follows.
L-ascorbic acid 2-glucoside : Product name "AA2G" (manufactured by Hayashibara Co., Ltd.)
Magnolia obovata extract : Trade name "Falcolex Magnolia B" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 0.175% by weight, Magnolia obovata Tumberg (Magnoliaceae) bark (Wakopaku) 1 , An extract obtained by solvent extraction treatment using an aqueous solution of 3-butylene glycol
Prunes extract : Trade name "Cleage" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 7.78% by weight, prunes (Prunus domestica Lindl. (Rosaceae)) flesh is a fibrinolytic enzyme Extract obtained by adding water and 1,3-butylene glycol to the one obtained by decomposition in
Artichoke leaf extract : Trade name "Biobenefity" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 0.08% by weight, leaves of Cynara scorymus L. (Composite) in ethanol solution Extract obtained by concentrating and drying the extract obtained by extraction and adding a 1,3-butylene glycol solution.
Herb robert extract : Brand name "Princess Care" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 1% by weight, from whole herb robert (Geraniium L. (Geraniaceae)) in 1,3-butylene glycol solution Extract obtained by extraction
Alpinia katsumadai seed extract : Brand name "Alpinia White" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 0.2% by weight, Alpinia katsumadai Hayata (Zingiberaceae) seeds in ethanol solution Extract obtained by concentrating the extract obtained by extraction and adding a 1,3-butylene glycol solution.
Chimpi extract : Trade name "Mandarinkria" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 3% by weight, mature peel of mandarin orange (Citrus reticulate Blanco (Rutaceae)) in 1,3-butylene glycol solution Extract obtained by extraction in
Bilberry leaf extract : trade name "Cure Berry" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid content concentration 0.2% by weight, 1,3-butylene glycol from bilberry (Vaccinium myrtillus L. (Ericaceae)) leaves Extract obtained by extracting with a solution
Carboxyvinyl polymer : Product name "Carbopol 980" (manufactured by Lubrizol Advanced Materials)
Alkyl-modified carboxyvinyl polymer : trade name "Carbopol ultraz20" (manufactured by Lubrizol Advanced Materials, carbon number of alkyl group: 10 to 30)
Silica : Product name "Godball D-25C" (manufactured by Suzuki Yushi Kogyo Co., Ltd.), average particle diameter 7-10 μm, specific surface area 300-500 m 2 / g, oil absorption 70-110 ml / 100 g
試験例1:メラニン生成抑制効果の評価
三次元培養皮膚モデル(MEL−300−A、MatTek社製)を用いて、メラニン生成抑制効果については評価した。具体的な試験方法は以下の通りである。
Test Example 1: Evaluation of melanin production inhibitory effect The melanin production inhibitory effect was evaluated using a three-dimensional cultured skin model (MEL-300-A, manufactured by MatTek). The specific test method is as follows.
MEL-300皮膚モデルカップを37℃に温めた維持培地(EPI-100LLMM)を0.9ml入れた6ウェルプレートの各ウェルにセットし、インキュベーター(37℃、5%CO2)に入れて1時間静置した。次いで、皮膚モデルカップの内部に、表1及び2に示す組成の各サンプル液(pH6.5)50μl加えて、インキュベーター(37℃、5%CO2)にて24時間培養を行った。その後、1回当たり0.5mW×12秒間の条件で紫外線(UV-B)照射を行い、更に24時間培養した。なお、紫外線照射は、UVBランプ(東芝ライテック社製、東芝健康線用蛍光ランプ)とUV検出器(TOPCON社製、UV−1)を用いて行った。その後、培地交換を行って、更に24時間培養した。なお、培地交換の都度、所定のサンプル液50μlを皮膚モデルカップに加えた。更に、同様の条件で紫外線照射と培地交換を繰り返し4回行うことにより、紫外線照射を計5回(合計紫外線照射量30mJ/cm2)、培地交換を計5回実施した。その後、以下に示す方法で、細胞生存率とメラニン生成量の測定を行った。また、コントロールとして、1,3−ブチレングリコールを0.5重量%含む水溶液をサンプル液として使用して、前記と同条件で試験を行った。 A MEL-300 skin model cup was set in each well of a 6-well plate containing 0.9 ml of maintenance medium (EPI-100LLMM) warmed to 37 ° C, and placed in an incubator (37 ° C, 5% CO 2 ) for 1 hour. It was left still. Next, 50 μl of each sample solution (pH 6.5) having the composition shown in Tables 1 and 2 was added to the inside of the skin model cup, and the cells were cultured in an incubator (37 ° C., 5% CO 2 ) for 24 hours. Then, it was irradiated with ultraviolet rays (UV-B) under the condition of 0.5 mW × 12 seconds each time, and cultured for another 24 hours. The ultraviolet irradiation was carried out using a UVB lamp (manufactured by Toshiba Lighting & Technology Corporation, a fluorescent lamp for Toshiba Health Line) and a UV detector (manufactured by TOPCON, UV-1). Then, the medium was exchanged, and the cells were further cultured for 24 hours. In addition, 50 μl of a predetermined sample solution was added to the skin model cup each time the medium was changed. Further, by repeating the ultraviolet irradiation and the medium exchange four times under the same conditions, the ultraviolet irradiation was carried out a total of five times (total ultraviolet irradiation amount 30 mJ / cm 2 ), and the medium exchange was carried out a total of five times. Then, the cell viability and the amount of melanin produced were measured by the methods shown below. As a control, an aqueous solution containing 0.5% by weight of 1,3-butylene glycol was used as a sample solution, and the test was conducted under the same conditions as described above.
<細胞活性の測定>
MTT試験により細胞生存率を測定した。具体的には、0.75mlのMTT試験薬と8.25mlの維持培地(EPI-100LLMM)を混合し、1ウェル当たり300μlとなるように添加した。皮膚モデルカップを、前記で調製したMTTの入った培地に移し、正確に3時間インキュベーターにて培養した。その後、組織の底面をPBS洗浄液で軽く洗浄して新しいプレートに移した。0.04N HCl酸性イソプロパノールを1mlずつ皮膚モデルカップの内側に添加し、蒸発しないようにプレートにカバーシールを貼り遮光して一晩インキュベーターにてブルーホルマザンを抽出した。抽出後、イソプロパノールをよく混ぜ合わせ、その内の200μlを96ウェルプレートに移した。マイクロプレートリーダーで570nmと620nmの光学濃度を測定し、それらの差をもって細胞活性とした。
<Measurement of cell activity>
Cell viability was measured by MTT test. Specifically, 0.75 ml of the MTT assay drug and 8.25 ml of the maintenance medium (EPI-100LLMM) were mixed and added so as to be 300 μl per well. The skin model cup was transferred to the medium containing the MTT prepared above and cultured in the incubator for exactly 3 hours. The bottom of the tissue was then lightly washed with PBS wash and transferred to a new plate. 1 ml of 0.04N HCl acidic isopropanol was added to the inside of the skin model cup, a cover seal was attached to the plate to prevent evaporation, and the blue formazan was extracted in an incubator overnight. After extraction, isopropanol was mixed well and 200 μl of it was transferred to a 96-well plate. The optical densities of 570 nm and 620 nm were measured with a microplate reader, and the difference between them was used as the cell activity.
<メラニン生成量の測定>
MEL-300皮膚モデルカップをPBSで洗浄後、メスで細胞組織を剥離して回収した。得られた細胞組織をPBSに浸し、破砕及び遠心(2,000rpm、10分)を行った。その後、上清を取り除き、更にエタノールとジメチルエーテルの混合液(エタノール:ジメチルエーテル=3:1(容量比))を加えて、撹拌及び遠心(2,000rpm、10分)を行った。次いで、上清を取り除き、乾燥させた。乾燥物に1N水酸化ナトリウム水溶液(10重量%DMSO含有)を添加し、90℃の水浴にて20分間処理し、加熱溶融させた。その後、加熱溶融させた溶液をボルテックスにて軽く撹拌し、室温まで冷却した後に、405nmの吸光度を測定し、メラニン生成量を求めた。
<Measurement of melanin production>
After washing the MEL-300 skin model cup with PBS, the cell tissue was peeled off with a scalpel and collected. The obtained cell tissue was immersed in PBS and crushed and centrifuged (2,000 rpm, 10 minutes). Then, the supernatant was removed, a mixed solution of ethanol and dimethyl ether (ethanol: dimethyl ether = 3: 1 (volume ratio)) was further added, and the mixture was stirred and centrifuged (2,000 rpm, 10 minutes). The supernatant was then removed and dried. A 1N aqueous sodium hydroxide solution (containing 10 wt% DMSO) was added to the dried product, treated in a water bath at 90 ° C. for 20 minutes, and heated and melted. Then, the heat-melted solution was lightly stirred with a vortex, cooled to room temperature, and then the absorbance at 405 nm was measured to determine the amount of melanin produced.
メラニン生成量を細胞生存率で除することにより、1細胞当たりのメラニン生成量を求めた。更に、コントロールの1細胞当たりのメラニン生成量を100として、各サンプル液を添加した場合の1細胞当たりのメラニン生成量の比率(メラニン生成比)を算出した。 The amount of melanin produced per cell was determined by dividing the amount of melanin produced by the cell viability. Further, the ratio of the amount of melanin produced per cell (melanin production ratio) when each sample solution was added was calculated with the amount of melanin produced per cell of the control being 100.
得られた結果を表1及び2に示す。この結果、ホオノキ抽出物単独(比較例2)では、メラニン生成抑制効果は認められず、アスコルビン酸2−グルコシド単独(比較例1)でも、メラニン生成抑制効果は不十分であった。また、アスコルビン酸2−グルコシドと、メラニン生成抑制効果が知られている植物抽出物(プルーン抽出物、チンピ抽出物、アーティチョーク葉抽出物、ビルベリー葉抽出物、アルピニア・カツマダイ種子抽出物、ヒメフウロ抽出物)を組み合わせた場合(比較例3〜8)でも、メラニン生成抑制効果の増強は殆ど認められなかった。 The results obtained are shown in Tables 1 and 2. As a result, no melanin production inhibitory effect was observed with the magnolia obovata extract alone (Comparative Example 2), and the melanin production inhibitory effect was insufficient even with ascorbic acid 2-glucoside alone (Comparative Example 1). In addition, ascorbic acid 2-glucoside and plant extracts known to suppress melanin production (prune extract, chimpi extract, artichoke leaf extract, bilberry leaf extract, alpinia katsumadai seed extract, Himefuuro extract) ) Was combined (Comparative Examples 3 to 8), but almost no enhancement of the melanin production inhibitory effect was observed.
これに対して、アスコルビン酸2−グルコシドとホオノキ抽出物を組み合わせた場合(実施例1〜11)には、メラニン生成抑制効果が格段に高まっていた。更に、アスコルビン酸2−グルコシド及びホオノキ抽出物と共に、プルーン抽出物を組み合わせた場合(実施例4〜8)では、メラニン生成抑制効果の飛躍的な向上が認められた。一方、スコルビン酸2−グルコシド及びホオノキ抽出物と共に、メラニン生成抑制作用が知られている他の植物抽出物(アーティチョーク葉抽出物、ヒメフウロ抽出物、アルピニア・カツマダイ種子抽出物)を組み合わせても、プルーン抽出物の場合程は、メラニン生成抑制効果の向上が認められなかった。 On the other hand, when the ascorbic acid 2-glucoside and the magnolia obovata extract were combined (Examples 1 to 11), the effect of suppressing melanin production was remarkably enhanced. Furthermore, when the prune extract was combined with the ascorbic acid 2-glucoside and the magnolia obovata extract (Examples 4 to 8), a dramatic improvement in the effect of suppressing melanin production was observed. On the other hand, when scorbic acid 2-glucoside and honoki extract are combined with other plant extracts known to have an inhibitory effect on melanin production (artichoke leaf extract, Himefuuro extract, Alpinia katsumadai seed extract), prune No improvement in the effect of suppressing melanin production was observed as in the case of the extract.
試験例2:使用感の評価
表3及び4に示す組成の皮膚化粧料(液剤)を調製した。具体的には、製造手順は以下の通りである。精製水にカルボキシビニルポリマー及びアルキル変性カルボキシビニルポリマーを撹拌溶解させた後に、グリセリンを加えて撹拌溶解させて、調製物Aを得た。別途、1,3−ブチレングリコールに、トリメチルグリシン及び/又はシリカを加え、撹拌混合して均一化し、調製物Bを得た。次いで、調製物Aを撹拌しながら、調製物Bを加え、ホモミキサーで撹拌し、均一化した。更に、水酸化カリウムを加えてpHを6.5に調整した後に、L−アスコルビン酸2−グルコシド、ホオノキ抽出物、及びプルーン抽出物を加えて撹拌し、均一化することにより、皮膚化粧料を調製した。
Test Example 2: Evaluation of usability A skin cosmetic (liquid) having the composition shown in Tables 3 and 4 was prepared. Specifically, the manufacturing procedure is as follows. After stirring and dissolving the carboxyvinyl polymer and the alkyl-modified carboxyvinyl polymer in purified water, glycerin was added and dissolved by stirring to obtain Preparation A. Separately, trimethylglycine and / or silica was added to 1,3-butylene glycol and stirred and mixed to homogenize to obtain Preparation B. Then, while stirring the preparation A, the preparation B was added, and the mixture was stirred with a homomixer to homogenize. Further, potassium hydroxide was added to adjust the pH to 6.5, and then L-ascorbic acid 2-glucoside, magnolia obovata extract, and prune extract were added and stirred to homogenize the skin cosmetics. Prepared.
得られた各皮膚化粧料について、以下の方法で、塗布時のしっかりとした塗布感、べたつき感のなさ及びさっぱり感、塗布後の粉っぽさのなさ及び保温感について評価した。 Each of the obtained skin cosmetics was evaluated by the following methods for a firm application feeling at the time of application, a non-sticky feeling and a refreshing feeling, a non-powderful feeling after application, and a heat retention feeling.
評価モニター10名が各皮膚化粧料約0.5gを腕に塗布して、塗布時のしっかりとした塗布感、べたつき感のなさ及びさっぱり感、並びに、塗布後の粉っぽさのなさ及び保湿感を評価した。具体的には、評価は、以下を「1」及び「10」としたVisual Analogue Scale(以下、VASと表記することもある)によるアンケートを実施することにより評点化した。アンケート結果を平均し、小数点第一位を四捨五入することにより、評価結果をまとめた。
<塗布時>
・塗布感
絡み付くような塗布感/ゲルを潰すような塗布感がない「1」
絡み付くような塗布感/ゲルを潰すような塗布感がある「10」
・さっぱり感
さっぱりとした感じがない「1」
さっぱりとした感じがある「10」
・べたつき感のなさ
べたつきを感じる「1」
べたつきを感じない「10」
<塗布から30秒後>
・粉っぽさのなさ
粉っぽさを感じる「1」
粉っぽさを感じない「10」
・保湿感
保湿感(しっとりとした感じ)がない「1」
保湿感(しっとりとした感じ)がある「l0」
Ten evaluation monitors applied about 0.5 g of each skin cosmetic to their arms, and they gave a firm feeling of application, no stickiness and refreshing feeling, and no powderiness and moisturizing after application. I evaluated the feeling. Specifically, the evaluation was scored by conducting a questionnaire by a Visual Analogue Scale (hereinafter, also referred to as VAS) in which the following were designated as "1" and "10". The evaluation results were summarized by averaging the questionnaire results and rounding off to the first decimal place.
<At the time of application>
・ Application feeling There is no entangled application feeling / application feeling that crushes the gel "1"
"10" with a feeling of entanglement / feeling of application that crushes the gel
・ Refreshing feeling "1" without a refreshing feeling
"10" with a refreshing feeling
・"1" that feels sticky without stickiness
"10" that does not feel sticky
<30 seconds after application>
・ No powderiness "1" that feels powdery
"10" that does not feel powdery
・ Moisturizing feeling "1" without moisturizing feeling (moist feeling)
"L0" with a moisturizing feeling (moist feeling)
得られた結果を表3及び4に示す。アスコルビン酸2−グルコシド、ホオノキ抽出物及びプルーン抽出物に加えて、水溶性増粘剤(カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー)、シリカ、及びトリメチルグリシンを含む場合には、しっかりとした塗布感、べたつき感のなさ、さっぱり感、粉っぽさのなさ及び保湿感の点で、満足できる結果になっていた。とりわけ、水溶性増粘剤1重量部に対してトリメチルグリシンが0.1〜6重量部を満たす場合には、しっかりとした塗布感、べたつき感のなさ、さっぱり感、粉っぽさのなさ及び保湿感が、極めて良好な結果であった。 The results obtained are shown in Tables 3 and 4. Firm application feeling when containing water-soluble thickeners (carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer), silica, and trimethylglycine in addition to ascorbic acid 2-glucoside, magnolia obovata extract and prune extract The results were satisfactory in terms of non-stickiness, refreshing feeling, non-powderiness and moisturizing feeling. In particular, when trimethylglycine fills 0.1 to 6 parts by weight with respect to 1 part by weight of the water-soluble thickener, it has a firm coating feeling, no stickiness, a refreshing feeling, and no powderiness. The moisturizing feeling was an extremely good result.
処方例1〜9
表5に記載の処方に従い、常法にて皮膚化粧料を調製した(処方例1〜6はpH6.5、処方例7〜9はpH4.5)。
Prescription Examples 1-9
Skin cosmetics were prepared by a conventional method according to the formulations shown in Table 5 (pH 6.5 for Formulation Examples 1 to 6 and pH 4.5 for Formulation Examples 7 to 9).
処方例10〜15
表6に記載の処方に従い、以下の手順で皮膚化粧料を調製した。
工程(1):精製水にL−アスコルビン酸2−グルコシド又はリン酸L−アスコルビルマグネシウムを溶解し、次いで、精製水に水酸化カリウムを溶解した液でpHを6に調整した(調製物(A−1))。
工程(2):(B)、(C)をそれぞれ加熱撹拌溶解した(調製物(B)、調製物(C))。
工程(3):調製物(B)を加熱撹拌しながら調製物(C)を加え、ホモミキサーで撹拌均一化した。
工程(4):その後、撹拌しながら徐々に40℃以下まで冷却し、調製物(A−1)と(A)の残りを加え、撹拌均一化し皮膚化粧料を調製した。
Prescription Examples 10 to 15
According to the formulation shown in Table 6, skin cosmetics were prepared according to the following procedure.
Step (1): L-ascorbic acid 2-glucoside or L-ascorbic magnesium phosphate was dissolved in purified water, and then the pH was adjusted to 6 with a solution in which potassium hydroxide was dissolved in purified water (preparation (A). -1)).
Step (2): (B) and (C) were dissolved by heating and stirring (preparation (B), preparation (C)), respectively.
Step (3): The preparation (C) was added while heating and stirring the preparation (B), and the mixture was made uniform by stirring with a homomixer.
Step (4): Then, the mixture was gradually cooled to 40 ° C. or lower with stirring, the rest of the preparations (A-1) and (A) were added, and the mixture was stirred and homogenized to prepare a skin cosmetic.
Claims (3)
The external composition according to claim 1 or 2, which is for whitening.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015192887A JP6807636B2 (en) | 2015-09-30 | 2015-09-30 | Topical composition |
PCT/JP2016/078546 WO2017057419A1 (en) | 2015-09-30 | 2016-09-27 | External composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015192887A JP6807636B2 (en) | 2015-09-30 | 2015-09-30 | Topical composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020168848A Division JP2021001227A (en) | 2020-10-06 | 2020-10-06 | External composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017066080A JP2017066080A (en) | 2017-04-06 |
JP6807636B2 true JP6807636B2 (en) | 2021-01-06 |
Family
ID=58423917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015192887A Active JP6807636B2 (en) | 2015-09-30 | 2015-09-30 | Topical composition |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6807636B2 (en) |
WO (1) | WO2017057419A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7429502B2 (en) * | 2019-06-20 | 2024-02-08 | 小林製薬株式会社 | External composition |
JP2021001126A (en) * | 2019-06-20 | 2021-01-07 | 小林製薬株式会社 | Agent for accelerating decomposition of melanosome in keratinocyte |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000119156A (en) * | 1998-10-14 | 2000-04-25 | Kose Corp | Skin lotion |
JP2004155702A (en) * | 2002-11-06 | 2004-06-03 | Hidekazu Itaka | Cosmetic using structurized concentrated deep layer water |
JP2006124355A (en) * | 2004-11-01 | 2006-05-18 | Ichimaru Pharcos Co Ltd | Phagocytosis inhibitor |
JP2006347926A (en) * | 2005-06-14 | 2006-12-28 | Ichimaru Pharcos Co Ltd | Phagocytosis inhibitor |
JP4732854B2 (en) * | 2005-10-31 | 2011-07-27 | 一丸ファルコス株式会社 | Peroxisome proliferator-responsive receptor activator |
JP5571897B2 (en) * | 2006-02-14 | 2014-08-13 | 株式会社ファンケル | Vitamin C transporter production promoter |
JP5840851B2 (en) * | 2011-03-25 | 2016-01-06 | 株式会社コーセー | Medicinal agent containing plum extract as active ingredient |
JP5730837B2 (en) * | 2012-11-05 | 2015-06-10 | 一丸ファルコス株式会社 | Melanin production inhibitor, moisturizer, whitening cosmetic, beauty food and drink |
-
2015
- 2015-09-30 JP JP2015192887A patent/JP6807636B2/en active Active
-
2016
- 2016-09-27 WO PCT/JP2016/078546 patent/WO2017057419A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2017066080A (en) | 2017-04-06 |
WO2017057419A1 (en) | 2017-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6766047B2 (en) | Γ-diketone for the treatment and prevention of aging skin and wrinkles | |
TW200412992A (en) | Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto | |
JP2012041302A (en) | Skin cosmetic | |
JP2005220084A (en) | Acerola seed extract-containing composition | |
JP2001163794A (en) | Promoter for production of hyaluronic acid and preparation for external use for skin | |
JP2005306831A (en) | Skin care preparation for external use | |
JP6781529B2 (en) | Skin care cosmetic composition | |
JP2004010526A (en) | Skin care preparation for external use | |
JP2002212087A (en) | Skin care preparation | |
JP6807636B2 (en) | Topical composition | |
KR100776755B1 (en) | Composition comprising crude drug extract showing anti-itching effect | |
CN112472629A (en) | Alpinia officinarum and amomum tsao-ko sun-proof emulsion and preparation method thereof | |
JP5863225B2 (en) | Skin care composition | |
JP2007045733A (en) | Hyaluronidase inhibitor | |
JP3987733B2 (en) | Fibroblast activator and skin external preparation containing the same | |
JPH11222412A (en) | Skin preparation for external use | |
JP5177827B2 (en) | Topical skin preparation | |
JP4592911B2 (en) | Cosmetics | |
JP4716497B2 (en) | External preparation for skin and hyaluronidase inhibitor | |
JP2021001227A (en) | External composition | |
KR101436819B1 (en) | Cosmetic composition for moisturing, soothing skin and improving acne | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
JP2004359603A (en) | Cell death inhibitor | |
WO2020255865A1 (en) | Topical composition | |
JP2004010505A (en) | Cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180827 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190903 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191031 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200204 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200331 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200402 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200707 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201006 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20201006 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20201022 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20201027 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201201 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201208 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6807636 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |